SNO 2022 Archives - Page 2 of 2 - Cancer Therapy Advisor

By

Jessica Nye, PhD

November 19, 2022

Recurrence of esthesioneuroblastoma with non-contiguous intracranial metastasis is possible 19 years after remission, a review suggests.

By

Jessica Nye, PhD

November 19, 2022

There are several steps health care providers can take to help patients with CNS cancers navigate the disability application process.

By

Jessica Nye, PhD

November 18, 2022

Tovorafenib produced responses in young patients with progressive or recurrent BRAF-altered low-grade glioma in a phase 2 trial.

By

Jessica Nye, PhD

November 18, 2022

The sequence of treatment with rolapitant and ondansetron does not appear to impact chemoradiation-induced nausea and vomiting.

By

Jessica Nye, PhD

November 18, 2022

About 1 in 10 patients with high-grade glioma had a palliative care consultation before the end-of-life phase, researchers found.

Diagnosis & Disease Information